Optimal allocation of HIV prevention funds for state health departments

PloS One
Emine YaylaliStephanie L Sansom

Abstract

To estimate the optimal allocation of Centers for Disease Control and Prevention (CDC) HIV prevention funds for health departments in 52 jurisdictions, incorporating Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program funds, to improve outcomes along the HIV care continuum and prevent infections. Using surveillance data from 2010 to 2012 and budgetary data from 2012, we divided the 52 health departments into 5 groups varying by number of persons living with diagnosed HIV (PLWDH), median annual CDC HIV prevention budget, and median annual HRSA expenditures supporting linkage to care, retention in care, and adherence to antiretroviral therapy. Using an optimization and a Bernoulli process model, we solved for the optimal CDC prevention budget allocation for each health department group. The optimal allocation distributed the funds across prevention interventions and populations at risk for HIV to prevent the greatest number of new HIV cases annually. Both the HIV prevention interventions funded by the optimal allocation of CDC HIV prevention funds and the proportions of the budget allocated were similar across health department groups, particularly those representing the large majority of PLWDH. Consis...Continue Reading

References

Mar 5, 1988·American Journal of Health Promotion : AJHP·A R TarlovJ A Ross
Aug 3, 1999·American Journal of Epidemiology·E VittinghoffS P Buchbinder
Jul 18, 2001·American Journal of Preventive Medicine·S C KalichmanJ Graham
Jan 26, 2002·BMJ : British Medical Journal·Peter R Lamptey
Apr 20, 2002·Epidemiology·Adaora A AdimoraTonya R Stancil
Sep 24, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mary Jane Rotheram-BorusMarguerita Lightfoot
Feb 11, 2005·The New England Journal of Medicine·Gillian D SandersDouglas K Owens
Mar 8, 2005·AIDS·Lytt I GardnerUNKNOWN Antiretroviral Treatment and Access Study Study Group
Nov 4, 2005·AIDS Care·B R SchackmanUNKNOWN CENTER FOR ADHERENCE SUPPORT AND EVALUATION (CASE) TEAM
Nov 30, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kenneth A FreedbergElena Losina
Dec 14, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Katherine AhrensJeffrey D Klausner
Jan 31, 2009·The Lancet Infectious Diseases·Marie-Claude BoilyMichel Alary
Apr 22, 2010·International Journal of Epidemiology·Rebecca F BaggaleyMarie-Claude Boily
Sep 23, 2010·AIDS·Kelly A GeboUNKNOWN HIV Research Network
Nov 5, 2010·The Journal of Sexual Medicine·Michael ReeceJ Dennis Fortenberry
Feb 10, 2011·Substance Use & Misuse·Samuel M JennessChristopher S Murrill
Jun 28, 2011·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Ram K ShresthaJames D Heffelfinger
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Nov 10, 2012·Preventing Chronic Disease·Tim McAfee, Michael Tynan
May 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lytt I GardnerUNKNOWN Retention in Care Study Group
Nov 26, 2014·Journal of Public Health Management and Practice : JPHMP·Jonathan E Fielding
Dec 4, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ram K ShresthaMichael Mugavero
Mar 8, 2016·American Journal of Preventive Medicine·Feng LinStephanie L Sansom

❮ Previous
Next ❯

Citations

May 14, 2019·Journal of Primary Care & Community Health·Alexis M RothKathleen A Brady
Nov 20, 2020·American Journal of Public Health·Stephanie L SansomDavid W Purcell
Nov 1, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Anton L V Avanceña, David W Hutton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.